PINK1/Parkin介导的线粒体自噬

线粒体自噬（mitochondrial autophagy, or mitophagy）指的是细胞通过自吞噬作用,降解与清除受损线粒体或者多余线粒体,其对整个线粒体网络的功能完整性和细胞存活具有重要作用。线粒体自噬过程受多种途径调控,PINK1/Parkin通路是其中的一条,其异常与多种疾病的发生密切相关,如心血管疾病、肿瘤和帕金森病等。在去极化线粒体中,磷酸酶及张力蛋白同源物(PTEN)诱导的激酶1（PTEN-induced kinase 1,PINK1）作为受损线粒体的分子传感器,触发线粒体自噬的起始信号,并将Parkin募集至线粒体;Parkin作为线粒体自噬信号的“增强子”,通过对线粒体蛋白质进一步泛素化介导自噬信号的扩大;去泛素化酶和PTEN-long蛋白参与调控该过程,并对维持线粒体稳态具有重要作用。本文主要对PINK1与Parkin蛋白质的分子结构和其介导线粒体自噬发生的分子机制,以及参与调控该途径的关键蛋白质进行综述,为进一步研究以线粒体自噬缺陷为特征的疾病治疗提供理论基础。     

Pink1/Parkin信号通路调控线粒体自噬的研究进展

线粒体自噬是指为了维持细胞内环境稳定而通过选择性自噬来降解功能失调或过剩的线粒体。在众多线粒体自噬相关通路研究中,对Pink1/Parkin信号通路的探索较为详细。在哺乳动物细胞中,Ser/Thr蛋白激酶Pink1和E3泛素连接酶Parkin协同作用,感知线粒体功能状态并对受损的线粒体进行标记,以促进其通过自噬途径进行降解。同时,泛素化和去泛素化在调节Parkin和线粒体自噬活性中起着重要的作用。本文就Pink1/Parkin信号通路以及去泛素化酶在线粒体自噬中的作用进行综述。     

TANK结合激酶1在PINK1/Parkin依赖性和非依赖性线粒体自噬中的作用研究进展

线粒体自噬是一种清除受损或多余线粒体的过程,在调节细胞内线粒体质量和维持线粒体能量代谢等方面发挥重要作用。TANK结合激酶1 (TANK-binding kinase 1, TBK1)是一种多功能的丝氨酸/苏氨酸蛋白激酶,同时参与调控PTEN诱导假定激酶1 (PTEN-induced putative kinase 1, PINK1)/Parkin依赖性和非依赖性线粒体自噬过程。近期研究表明,TBK1可磷酸化视神经蛋白(optineurin, OPTN)、p62/sequestosome-1、Ras相关GTP结合蛋白7 (Ras-related GTP binding protein 7, Rab7)等自噬相关蛋白,并介导核点蛋白52 (nuclear dot protein 52, NDP52)与UNC-51样自噬激活激酶1 (UNC-51 like autophagy activating kinase 1, ULK1)复合物相结合,以及TAX1结合蛋白1 (TAX1-binding protein 1, TAX1BP1)与微管相关蛋白1轻链3 (microtubule-assoc...     

线粒体自噬与心肌保护

线粒体自噬是指细胞通过自噬的机制选择性地清除线粒体的过程。通过该途径,细胞可降解并清除受损或功能障碍的线粒体,以维持细胞内线粒体质量和数量的平衡,从而维持细胞稳态。在生理状态及应激状态下,多种因子可调控心肌细胞线粒体自噬,进而发挥保护心肌细胞的作用。本文就线粒体自噬及其调控机制以及其在心肌保护中的作用做一综述。     

线粒体动力学及线粒体自噬调控机制的研究进展

线粒体形态和功能的异常与多种疾病的发生密切相关。线粒体通过不断的分裂和融合,维持线粒体网络的动态平衡,该过程称为线粒体动力学,是维持线粒体形态、分布和数量,保证细胞稳态的重要基础。此外,机体还通过线粒体自噬过程降解胞内功能异常的线粒体,维持线粒体稳态。线粒体动力学与线粒体自噬二者之间可相互调控,共同维持线粒体质量平衡。探讨线粒体动力学和线粒体自噬的调控机制对揭示多种疾病发生的分子机制、开发新的靶向线粒体动力学蛋白或线粒体自噬调控蛋白的药物具有重要意义。本文从线粒体动力学与线粒体自噬出发,对线粒体动力学调控机制、线粒体自噬及其发生机制以及二者的相互作用关系、线粒体动力学及线粒体自噬与人类相关疾病等方面作一综述。     

Parkin、PINK1、DJ-1和线粒体功能障碍与帕金森病

帕金森病(Parkinson’s disese,PD)是一种常见的神经退行性疾病,但到目前为止发病机制尚不明确,环境和遗传等因素与其发病有密切关系。研究表明,蛋白质异常积聚(泛素/蛋白酶体途径)和线粒体氧化损伤(线粒体途径),可能是导致PD患者发病的关键分子机制。Parkin、PINK1和DJ-1等基因突变与常染色体隐性的家族性PD有关,这些相关基因编码的蛋白对于维持线粒体形态和功能起着重要的作用。本文将主要从Parkin、PINK1、DJ-1和线粒体功能障碍与帕金森病的关系进行综述。     

线粒体自噬的研究进展

线粒体自噬（mitophagy）是指细胞通过自噬的机制选择性地清除线粒体的过程。选择性清除受损伤或功能不完整的线粒体对于整个线粒体网络的功能完整性和细胞生存来说十分关键。线粒体自噬的异常和很多疾病密切相关,因此对于线粒体自噬的具体分子机制以及生理意义研究有很重要的生物学意义。线粒体自噬的研究是目前生物学领域的研究热点,该文主要综述了近年来在线粒体自噬领域取得的研究进展,旨在为相关领域的研究提供参考。     

线粒体自噬进程及其受病毒感染的影响

线粒体自噬(mitophagy)属于巨自噬的范畴,即受损线粒体被一种双层膜结构(如粗面内质网的无核糖体附着区脱落的双层膜)包裹后形成自噬小体(autophagosome),接着自噬小体的外膜与溶酶体膜融合,底物蛋白进入溶酶体,最终被各类水解酶降解的一系列过程.然而,一些病毒的细胞感染过程与线粒体自噬的发生有着密切联系.本文对线粒体自噬发生的前提条件、起始与发展的全过程以及病毒感染对线粒体自噬的影响等进行综述,以期为进一步研究线粒体自噬提供新思路.     

Parkin介导的线粒体自噬及细胞器互作机制

线粒体是细胞生理代谢活动发生的重要场所.线粒体生发降解平衡是维持能量代谢稳定的重要保障.Parkin作为E3泛素连接酶,通过PINK1/Parkin、LC3等多种信号参与调控线粒体自噬过程.此外,Parkin还能够影响线粒体相关内质网膜、调控细胞器间钙流,在线粒体-内质网对话过程中调控溶酶体途径介导的线粒体自噬.脂肪组...     

线粒体自噬的研究进展

线粒体自噬(mitophagy)是指细胞通过自噬机制选择性清除多余或损伤线粒体的过程,对于线粒体质量控制以及细胞生存具有重要作用。在线粒体自噬的过程中,线粒体自噬受体FUNDCl、Nix、BNIP3,接头蛋白OPTN、NDP52以及去泛素化酶UPS30、UPS8等发挥了重要的调控作用。近年来,研究发现线粒体自噬与神经退行性疾病、脑损伤以及胶质瘤相关。因此,研究线粒体自噬的分子机制具有重要意义。本文就与哺乳动物相关的线粒体自噬分子机制及最新研究进展做一综述。     

Cannabidiol activates PINK1-Parkin-dependent mitophagy and mitochondrial-derived vesicles

The PINK1/Parkin pathway plays an important role in maintaining a healthy pool of mitochondria. Activation of this pathway can lead to apoptosis, mitophagy, or mitochondrial-derived vesicle formation, depending on the nature of mitochondrial damage. The signaling by which PINK/Parkin activation leads to these different mitochondrial outcomes remains understudied. Here we present evidence that cannabidiol (CBD) activates the PINK1-Parkin pathway in a unique manner. CBD stimulates PINK1-dependent Parkin mitochondrial recruitment similarly to other well-studied Parkin activators but with a distinctive shift in the temporal dynamics and mitochondrial fates. The mitochondrial permeability transition pore inhibitor cyclosporine A exclusively diminished the CBD-induced PINK1/Parkin activation and its associated mitochondrial effects. Unexpectedly, CBD treatment also induced elevated production of mitochondrial-derived vesicles (MDV), a potential quality control mechanism that may help repair partial damaged mitochondria. Our results suggest that CBD may engage the PINK1-Parkin pathway to produce MDV and repair mitochondrial lesions via mitochondrial permeability transition pore opening. This work uncovered a novel link between CBD and PINK1/Parkin-dependent MDV production in mitochondrial health regulation.     

Loss of iron triggers PINK1/Parkin‐independent mitophagy

In this study, we develop a simple assay to identify mitophagy inducers on the basis of the use of fluorescently tagged mitochondria that undergo a colour change on lysosomal delivery. Using this assay, we identify iron chelators as a family of compounds that generate a strong mitophagy response. Iron chelation‐induced mitophagy requires that cells undergo glycolysis, but does not require PINK1 stabilization or Parkin activation, and occurs in primary human fibroblasts as well as those isolated from a Parkinson's patient with Parkin mutations. Thus, we have identified and characterized a mitophagy pathway, the induction of which could prove beneficial as a potential therapy for several neurodegenerative diseases in which mitochondrial clearance is advantageous.     

PINK1 is recruited to mitochondria with parkin and associates with LC3 in mitophagy

Mutations in PTEN-induced putative kinase 1 (PINK1) cause recessive form of Parkinson’s disease (PD). PINK1 acts upstream of parkin, regulating mitochondrial integrity and functions. Here, we show that PINK1 in combination with parkin results in the perinuclear mitochondrial aggregation followed by their elimination. This elimination is reduced in cells expressing PINK1 mutants with wild-type parkin. Although wild-type PINK1 localizes in aggregated mitochondria, PINK1 mutants localization remains diffuse and mitochondrial elimination is not observed. This phenomenon is not observed in autophagy-deficient cells. These results suggest that mitophagy controlled by the PINK1/parkin pathway might be associated with PD pathogenesis.

Structured summary

MINT-7557195: PINK1 (uniprotkb:Q9BXM7) physically interacts (MI:0915) with LC3 (uniprotkb:Q9GZQ8) by anti tag coimmunoprecipitation (MI:0007)MINT-7557109: LC3 (uniprotkb:Q9GZQ8) and PINK1 (uniprotkb:Q9BXM7) colocalize (MI:0403) by fluorescence microscopy (MI:0416)MINT-7557121: tom20 (uniprotkb:Q15388) and PINK1 (uniprotkb:Q9BXM7) colocalize (MI:0403) by fluorescence microscopy (MI:0416)MINT-7557138: parkin (uniprotkb:O60260), PINK1 (uniprotkb:Q9BXM7) and tom20 (uniprotkb:Q15388) colocalize (MI:0403) by fluorescence microscopy (MI:0416)MINT-7557173: LC3 (uniprotkb:Q9GZQ8) physically interacts (MI:0915) with PINK1 (uniprotkb:Q9BXM7) by anti bait coimmunoprecipitation (MI:0006)     

Unconventional initiation of PINK1/Parkin mitophagy by Optineurin

1. Download : Download high-res image (161KB)
2. Download : Download full-size image

     

Short Mitochondrial ARF Triggers Parkin/PINK1-dependent Mitophagy

Parkinson disease (PD) is a complex neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra. Multiple genes have been associated with PD, including Parkin and PINK1. Recent studies have established that the Parkin and PINK1 proteins function in a common mitochondrial quality control pathway, whereby disruption of the mitochondrial membrane potential leads to PINK1 stabilization at the mitochondrial outer surface. PINK1 accumulation leads to Parkin recruitment from the cytosol, which in turn promotes the degradation of the damaged mitochondria by autophagy (mitophagy). Most studies characterizing PINK1/Parkin mitophagy have relied on high concentrations of chemical uncouplers to trigger mitochondrial depolarization, a stimulus that has been difficult to adapt to neuronal systems and one unlikely to faithfully model the mitochondrial damage that occurs in PD. Here, we report that the short mitochondrial isoform of ARF (smARF), previously identified as an alternate translation product of the tumor suppressor p19ARF, depolarizes mitochondria and promotes mitophagy in a Parkin/PINK1-dependent manner, both in cell lines and in neurons. The work positions smARF upstream of PINK1 and Parkin and demonstrates that mitophagy can be triggered by intrinsic signaling cascades.     

Mitophagy and Parkinson's disease: The PINK1-parkin link

The study of rare, inherited mutations underlying familial forms of Parkinson's disease has provided insight into the molecular mechanisms of disease pathogenesis. Mutations in these genes have been functionally linked to several key molecular pathways implicated in other neurodegenerative disorders, including mitochondrial dysfunction, protein accumulation and the autophagic-lysosomal pathway. In particular, the mitochondrial kinase PINK1 and the cytosolic E3 ubiquitin ligase parkin act in a common pathway to regulate mitochondrial function. In this review we discuss the recent evidence suggesting that the PINK1/parkin pathway also plays a critical role in the autophagic removal of damaged mitochondria-mitophagy. This article is part of a Special Issue entitled Mitochondria: the deadly organelle.     

Regulation by mitophagy

Eukaryotes employ elaborate mitochondrial quality control to maintain the function of the power-generating organelle. Mitochondrial quality control is particularly important for the maintenance of neural and muscular tissues. Mitophagy is specialized version of the autophagy pathway. Mitophagy delivers damaged mitochondria to lysosomes for degradation. Recently, a series of elegant studies have demonstrated that two Parkinson's disease-associated genes PINK1 and parkin are involved in the maintenance of healthy mitochondria as mitophagy. Parkin in co-operation with PINK1 specifically recognizes damaged mitochondria with reduced mitochondrial membrane potential (Δψm), rapidly isolates them from the mitochondrial network and eliminates them through the ubiquitin–proteasome and autophagy pathways. Here we introduce and review recent studies that contribute to understanding the molecular mechanisms of mitophagy such as PINK1 and Parkin-mediated mitochondrial regulation. We also discuss how defects in the PINK1–Parkin pathway may cause neurodegeneration in Parkinson's disease.     

GPD1L inhibits renal cell carcinoma progression by regulating PINK1/Parkin-mediated mitophagy

Few approaches have been conducted in the treatment of renal cell carcinoma (RCC) after nephrectomy, resulting in a high mortality rate in urological tumours. Mitophagy is a mechanism of mitochondrial quality control that enables selective degradation of damaged and unnecessary mitochondria. Previous studies have found that glycerol-3-phosphate dehydrogenase 1-like (GPD1L) is associated with the progression of tumours such as lung cancer, colorectal cancer and oropharyngeal cancer, but the potential mechanism in RCC is still unclear. In this study, microarrays from tumour databases were analysed. The expression of GPD1L was confirmed by RT–qPCR and western blotting. The effect and mechanism of GPD1L were explored using cell counting kit 8, wound healing, invasion, flow cytometry and mitophagy-related experiments. The role of GPD1L was further confirmed in vivo. The results showed that GPD1L expression was downregulated and positively correlated with prognosis in RCC. Functional experiments revealed that GPD1L prevented proliferation, migration and invasion while promoting apoptosis and mitochondrial injury in vitro. The mechanistic results indicated that GPD1L interacted with PINK1, promoting PINK1/Parkin-mediated mitophagy. However, inhibition of PINK1 reversed GPD1L-mediated mitochondrial injury and mitophagy. Moreover, GPD1L prevented tumour growth and promoted mitophagy by activating the PINK1/Parkin pathway in vivo. Our study shows that GPD1L has a positive correlation with the prognosis of RCC. The potential mechanism involves interacting with PINK1 and regulating the PINK1/Parkin pathway. In conclusion, these results reveal that GPD1L can act as a biomarker and target for RCC diagnosis and therapy.     

Dendrobium nobile Lindl. alkaloids alleviate Mn-induced neurotoxicity via PINK1/Parkin-mediated mitophagy in PC12 cells

Modern pharmacological studies have demonstrated that Dendrobium nobile Lindl. Alkaloids (DNLA), the main active ingredients of Dendrobium nobile, is valuable as an anti-aging and neuroprotective herbal medicine. The present study was designed to determine whether DNLA confers protective function over neurotoxicant manganese (Mn)-induced cytotoxicity and the mechanism involved. Our results showed that pretreatment of PC12 cells with DNLA alleviated cell toxicity induced by Mn and improved mitochondrial respiratory capacity and oxidative status. Mn treatment increased apoptotic cell death along with a marked increase in the protein expression of Bax and a decrease in the expression of Bcl-2 protein, all of which were noticeably reversed by DNLA. Furthermore, DNLA significantly abolished the decrease in protein levels of both PINK1 and Parkin, and mitigated the increased expression of autophagy marker LC3-II and accumulation of p62 caused by Mn. These results demonstrate that DNLA inhibits Mn induced cytotoxicity, which may be mediated through modulating PINK1/Parkin-mediated autophagic flux and improving mitochondrial function.